The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
pH-Activated Nanoparticles for Controlled Topical Delivery of Farnesol To Disrupt Oral Biofilm Virulence
Open accessAbstract
Development of effective therapies to control oral biofilms is challenging, as topically introduced agents must avoid rapid clearance from biofilm-tooth interfaces while targeting biofilm microenvironments. Additionally, exopolysaccharides-matrix and acidification of biofilm microenvironments are associated with cariogenic (caries-producing) biofilm virulence. Thus, nanoparticle carriers capable of binding to hydroxyapatite (HA), saliva-coated HA (sHA), and exopolysaccharides with enhanced drug release at acidic pH were developed. Nanoparticles are formed from diblock copolymers composed of 2-(dimethylamino)ethyl methacrylate (DMAEMA), butyl methacrylate (BMA), and 2-propylacrylic acid (PAA) (p(DMAEMA)-b-p(DMAEMA-co-BMA-co-PAA)) that self-assemble into ∼21 nm cationic nanoparticles. Nanoparticles exhibit outstanding adsorption affinities (∼244 L-mmol(-1)) to negatively charged HA, sHA, and exopolysaccharide-coated sHA due to strong electrostatic interactions via multivalent tertiary amines of p(DMAEMA). Owing to hydrophobic cores, nanoparticles load farnesol, a hydrophobic antibacterial drug, at ∼22 wt %. Farnesol release is pH-dependent with t1/2 = 7 and 15 h for release at pH 4.5 and 7.2, as nanoparticles undergo core destabilization at acidic pH, characteristic of cariogenic biofilm microenvironments. Importantly, topical applications of farnesol-loaded nanoparticles disrupted Streptococcus mutans biofilms 4-fold more effectively than free farnesol. Mechanical stability of biofilms treated with drug-loaded nanoparticles was compromised, resulting in >2-fold enhancement in biofilm removal under shear stress compared to free farnesol and controls. Farnesol-loaded nanoparticles effectively attenuated biofilm virulence in vivo using a clinically relevant topical treatment regimen (2×/day) in a rodent dental caries disease model. Strikingly, treatment with farnesol-loaded nanoparticles reduced both the number and severity of carious lesions, while free farnesol had no effect. Nanoparticle carriers have great potential to enhance the efficacy of antibiofilm agents through multitargeted binding and pH-responsive drug release due to microenvironmental triggers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Flemming, H.-C., & Wingender, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2415 · Cited by 10,137
Understanding biofilm resistance to antibacterial agents
Davies, D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,781
The Role of Bacteria in the Caries Process: Ecological Perspectives
Takahashi, N., & Nyvad, B. (2011) · Journal of Dental Research · doi:10.1177/0022034510379602 · Cited by 1,199
Bowen, W. H., & Koo, H. (2011) · Caries Research · doi:10.1159/000324598 · Cited by 1,051
Self-citationSato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D. D., Golub, E., & Rodan, G. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115539 · Cited by 1,004
Nancollas, G. H., Tang, R., Phipps, R. J., Henneman, Z., Gulde, S., Wu, W., Mangood, A., Russell, R. G. G., & Ebetino, F. H. (2006) · Bone · doi:10.1016/j.bone.2005.05.003 · Cited by 862
The Challenge of Treating Biofilm-associated Bacterial Infections
del Pozo, J. L., & Patel, R. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100247 · Cited by 671
Streptococcus Adherence and Colonization
Nobbs, A. H., Lamont, R. J., & Jenkinson, H. F. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00014-09 · Cited by 657
Wilson, W. W., Wade, M. M., Holman, S. C., & Champlin, F. R. (2001) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(00)00224-4 · Cited by 626
pH-Responsive Copolymer Assemblies for Controlled Release of Doxorubicin
Gillies, E. R., & Fréchet, J. M. J. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049851c · Cited by 550
Cited by
The Oral Microbiota: Dynamic Communities and Host Interactions
Lamont, R. J., Koo, H., & Hajishengallis, G. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0089-x · Cited by 2,217
Targeting microbial biofilms: current and prospective therapeutic strategies
Koo, H., Allan, R. N., Howlin, R. P., Stoodley, P., & Hall-Stoodley, L. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.99 · Cited by 1,800
Self-citationPolymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Oral Biofilms: Pathogens, Matrix, and Polymicrobial Interactions in Microenvironments
Bowen, W. H., Burne, R. A., Wu, H., & Koo, H. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2017.09.008 · Cited by 1,059
Self-citationNanotechnology-based antimicrobials and delivery systems for biofilm-infection control
Liu, Y., Shi, L., Su, L., van der Mei, H. C., Jutte, P. C., Ren, Y., & Busscher, H. J. (2019) · Chemical Society Reviews · doi:10.1039/c7cs00807d · Cited by 737
The oralome and its dysbiosis: New insights into oral microbiome-host interactions
Radaic, A., & Kapila, Y. L. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.02.010 · Cited by 467
Liu, Y., Busscher, H. J., Zhao, B., Li, Y., Zhang, Z., van der Mei, H. C., Ren, Y., & Shi, L. (2016) · ACS Nano · doi:10.1021/acsnano.6b01370 · Cited by 379
Self-citationNaha, P. C., Liu, Y., Hwang, G., Huang, Y., Gubara, S., Jonnakuti, V., Simon-Soro, A., Kim, D., Gao, L., Koo, H., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b08702 · Cited by 367
Self-citationGao, L., Liu, Y., Kim, D., Li, Y., Hwang, G., Naha, P. C., Cormode, D. P., & Koo, H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.051 · Cited by 324
Self-citationAdvanced smart biomaterials and constructs for hard tissue engineering and regeneration
Zhang, K., Wang, S., Zhou, C., Cheng, L., Gao, X., Xie, X., Sun, J., Wang, H., Weir, M. D., Reynolds, M. A., et al. (2018) · Bone Research · doi:10.1038/s41413-018-0032-9 · Cited by 317
The Evolving Microbiome of Dental Caries
Spatafora, G., Li, Y., He, X., Cowan, A., & Tanner, A. C. R. (2024) · Microorganisms · doi:10.3390/microorganisms12010121 · Cited by 285
Self-citationAdvancing antimicrobial strategies for managing oral biofilm infections
Jiao, Y., Tay, F. R., Niu, L.-N., & Chen, J.-H. (2019) · International Journal of Oral Science · doi:10.1038/s41368-019-0062-1 · Cited by 280
Infection microenvironment-related antibacterial nanotherapeutic strategies
Wang, Z., Liu, X., Duan, Y., & Huang, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121249 · Cited by 268
Bioresponsive Nanoparticles Targeted to Infectious Microenvironments for Sepsis Management
Zhang, C. Y., Gao, J., & Wang, Z. (2018) · Advanced Materials · doi:10.1002/adma.201803618 · Cited by 222
Wang, L., Li, Y., Ren, M., Wang, X., Li, L., Liu, F., Lan, Y., Yang, S., & Song, J. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.02.008 · Cited by 91
Self-citationCariogenic Biofilm: Pathology-Related Phenotypes and Targeted Therapy
Chen, X., Daliri, E. B.-M., Tyagi, A., & Oh, D.-H. (2021) · Microorganisms · doi:10.3390/microorganisms9061311 · Cited by 50
Metadata
- Authors
- Horev, B., Klein, M. I., Hwang, G., Li, Y., Kim, D., Koo, H., & Benoit, D. S. W.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-02-13
- Volume
- 9
- Issue
- 3
- Pages
- 2390-2404
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2059631164
- Cited by
- 340
- References
- 72
- FWCI
- 14.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.